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Iranian J Parasitol: Vol. 5, No.1, 2010, pp . 47 - 54       47                                                        Original  Article     The  Role of Liposomal  Cp G   ODN   on  the Course of  L . major   Infec - tion   in  BALB /C Mice     H Hejazi 1 , M Tasbihi 1 , MR Jaafari 2 , A Badiee 2 , N Peste chian 1 , A Javadi 3 ,  * A   Khamesi - pour 4*     1 -   Department  of Parasitology, Isfahan University of Medical Sciences, Isfahan, Iran   2 -  Biotechnology Research Center and  Nanotechnology  Research Center ,  School of Pharmacy,  Mash - had University of Medical Sciences ,  Mashhad, Iran   3 -  Department of Social Medicine, Qazvin  University of Medical Sciences, Qazvin, Iran   4 -  Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sci - ences, Tehran, Iran     (Received 21  Sep  2009; accepted  22   Jan  20 10 )     Abstract   Background :  Historically ,   l eishmani zation is the most effective protective measure against  Cutaneous  Leishmaniasis ( CL ),  CL lesion induced by  leishmanization  sometimes  takes a long time to heal.  Ma - nipulation of  leishmanization  inoculums needed to induce a mild and acceptable CL lesion.  The  aim of  this study was to explore if liposomal form of CpG ODN (Cytosin phosphate Guanin  Oligodeoxynu - cleotides ) mixed with  Leishmania major     would  induce a milder lesion size  in Balb/c mice.   Methods:   This  study  was performed in  Biotechnology Research Cen ter,  Mashhad, and   Center for Re - search and Training in Skin Diseases and Leprosy,  Tehran, Iran during 2008 - 2009.  Different groups of  BALB/c  mice  were subcutaneously (SC) inoculated with  L. major  mixed with liposomal form of CpG  ODN , or  L. major   plus  free C pG ODN, or  L. major  mixed  with  empty liposom e s or  L. major  in PBS .  The lesion onset and the size  of lesion  were recorded; the death rate was also monitored.     Result :  Footpad  thickness  was  significantly  ( P <0.01)  smaller,  death  rate  was  also  significantly  ( P <0.05) lower in the mice received  L. major  mixed with liposomal CpG ODN or free CpG ODN than  control groups  received  L. major  in PBS or  L. major  plus liposomes , also mice which received  L. ma - jor  mixed with CpG ODN in soluble form showed a significantly ( P  < 0.001) smaller lesion size than  control groups.    Conclusion :  CpG ODN seems to be an appropriate immunopotentiator mixed with  Leishmania  stabi - late in  leishmanization .     Key words:     CpG ODN ,  Liposome ,  Leishmania major , BALB/c                                                         *   Corresponding  A uthor : F ax: +9 8 21 8897 0658.    E - mail  khamesipour_ali@yahoo.com         Iranian J Parasitol     Open access Journal at   http:// ijpa.tums.ac.ir       Tehran University of  Medical Sciences  Publ i cation   http:// tums.ac.i r     Iranian Society of  Par a sitology   http:// isp.tums.ac.ir  Hejazi et al.: The Role of Liposomal  Cp g ODN…     48   Introduction     utaneous L eishmaniasis ( CL )   is  a   ma - jor  health  problem   in  some  endemic  areas , in cluding Iran  ( 1 ) .   Search for an  effective vac cine  against leishmaniasis  seems  to be  the  sole control measure .   Various forms  of  Leishmania  antigens,  such as ;   recombinant   L eishmania  anti gens   and  live  attenuated  para - sites ,   have  been  used  to  immunize  against  murine model  of leishmaniasis  ( 2 - 4 ) .   I nduc - tion  of  protection  in  animal  model  of  leishmania s is  is possible ,   but  today  there is no  vaccine  available  against  any  form  of  leishmaniasis ,   r egardless  of  global  attempts   ( 5 - 7 ) .   Leishmanization   showed to be the most  effective  tool  against  CL   ( 5 ,  8,  9 ) .  It  was  stopped  due  to  lack  of  standardization,  and  unexpected  prolonged  lesion  at  the  site  of  leishmanization  ( 10,  5 ) .   Bacterial  DNA  en - hance s  in nate and adaptive immune responses  ( 11 ,   12 ).  Stimulation of immune  responses by   bacterial DNA  is  due to the presence of  un - methylated   Cytosine - Guanine  nucleotides   motif  in DNA  sequences .  Synthetic  oligode - o xynucleotide s   containing  un methyl ated  gua - nine  cyt osine  moti f   (CpG   ODN)  mimic   the  stimulating effect of bacteria l  DNA  ( 11, 12 ) .   Using  CpG ODN as an adjuvant  mixed with  L .  major  ribosomal proteins or  p romastigote   antigens  or  r ecombinant  Leishmania   protein  induced protection  and even curative effect on  L. m ajor  infection  ( 13 - 15 ) .     Liposomes  are  artificial closed vesicles com - posed of concentric lipid bilayers, separated  by aqueous domains  and utilized as delivery  systems  for  drugs,  peptides,  proteins  and  DNA  ( 16,   17 ) .   E ncapsulation  of  CpG  ODN  into liposomes   extend s  the duration of CpG  ODN activity  ( 18 ).    I n this study,  L. major  promastigotes were   co - inoculat ed   with  CpG  ODN  encapsulated   in  l iposome s or   in free form   subcutaneously  into  susceptible BALB/c mice .   T he lesion size and  the death rate  were evaluated  i n  immunized  mice   and  compared with the control group s .     Material s  and  M ethods       In this  experimental study ,  performed   during   2008 - 2009 ,  preparation  of  liposoms  and  en - capsulation of CpG ODN into liposomes were  done  in  Biotechnology  Research  Center ,   Mashhad ,  Mashhad, Iran  and animal experi - ments were done in  Center for Research and  Training in Skin Diseases and  Leprosy, Te - hran University of Medical Sciences, Tehran,  Iran .     Animals   Forty f emale BALB/c mice  aged  6 - 8 weeks  old  were  purchased  from  Pasteur  Insti tute   ( Tehran ,  Iran ).  The mice were maintained in  animal  house  of  Center  for  Research  and  Training  in  Skin  Diseases  and  Leprosy  and  fed  with  tap  water  and  standard  laboratory  diet.  Animals were housed in a colony room  with a 12 - h - 12 - h light - dark cycle at 21 º C  with   free access to water and food.     Parasites   Leishmania  major   (MRHO/IR/75/ER)  w as   grown in Novy - MacNeal - Nicole (NNN)   me - dium, and for mass production,  the  promas - tigotes  were  subcultured  in   RPMI  (Sigma,  Germany)  supplemented  with  0.2  mM  L - glutamine,  1 00  U/ml  penicillin,  100  µg  streptomycin  and  15%  f etal  b ovine  s erum.   The promastigotes were harvested at station - ary phase (stationary phase was estimated by  daily enumeration of parasite number).   CpG ODN:   CpG ODN 1826  (Microsynth, Balgach, Swit - zerland) , w as  a 20 - mer  (5' - TCC ATG ACG  TTC  CTG  ACG  TT - 3')  with   a  nuclease - re - sistant phosphorothioate backbone containing  two CpG motifs ( marked as  bold) known to  show  an   immunostimulatory  effect  on  Th1  response in  murine  model  ( 19 ).     Encapsulated of CpG ODN in lipos ome   Liposome s   containing  CpG  ODN  were  pre - pared  by the dehydration - rehydration  v esicle  (DRV) method ( 20 ). The lipid phase consist - ing  of  1,2 - distearoyl - sn - glycero - 3 - phospho - choline   ( DSPC ),   1,2  dioleoyl   propyl  3   trimethylammonium  bromide  ( DOTAB )  and  cholest erol dissolved in chloroform:methanol   (2:1 :1 ,v/v)   in a round bottom flask. The sol - vent was removed by rotary evaporation re - sulting in deposition of a thin lipid film on the  flask ’ s   wall. The lipid film was freeze - dried  overnight to ensure total removal o f the sol - C  Iranian J Parasitol: Vol. 5, No.1, 2010, pp . 47 - 54       49   vent.  The  lipid  film  was  then  hydrated  and  dispersed  in  distilled  water  using  vortex  at  55 °C. The resulting empty multilamellar vesi - cles   (MLVs) were converted to 100   nm small  unilamellar  vesicles   (SUVs)  using  the  mini - extruder   (Avastin,  Canada) .   The  CpG  ODN  were then added to empty SUV s  liposomes,   dried  with  freeze - drier  overnight  and  rehy - drated by distilled water. CpG  ODN, which  remained  not  encapsulated,   was  removed  from  encapsulated  ones   by   centrifugation  at  14,000   ×   g for 15 min at 4   °C .   Opt ical microscope (Olympus, Germany) was  used  to  study  the  morphological  features  of  liposomes. The particle size distribution and  mean diameter of liposomes  were determined  by a particle size analyzer ( Malvern ,  UK ).     Encapsulation efficiency of CpG ODN into   liposomes    The  efficiency  of  incorporation  (%  entrap - ment) of CpG ODN in liposome was deter - mined using UV absorption at 260 nm. The  analysis was performed on supernatants fol - lowing  PBS  washes.  The  percentage  of  en - trapment was calculated as described be fore  ( 17 ). The concentration of   CpG ODN in the  liposomes w as  adjusted to 10  m g/50  m l after  purification and calculation of percent of en - trapment.     Induction of  lesion   in  BALB/c mice   BALB/c mice  (10 per group)  were in oculated  SC  in the right footpad with  2   ×   10 6   L. major ,    promastigotes  har v ested  at  stationary   phase  mixed  with   either  CpG  ODN   (10µg) ,   lipo - somal  CpG ODN   (10µg CpG ODN),   empty  liposome or PBS  in  final volume  of  60µl .  The  development of lesion   was  monitored and  re - corded  in  each  mouse  by  weekly  measure - ment of footpad thickness using a metric cali - per .   Grading of lesion size was done   by sub - tracting the thickness of the uninfected  con - tralateral  footpad from that of the infected one   ( 18 ) .     Statistical  a nalysis   Repeated  measurement  ANOVA  statistic al  tes t  was used to  assess  the  significance  of  the   differences  among  various  groups.   Bonfroni  test was used to compare the means of differ - ent treatment groups. Results with  p  values of  <   0.05  were  considered  statistically  signifi - cant.      Ethical considera tions   Animal experiments were carried out accord - ing to Tehran University of Medical Sciences,  Ethical  Committee  Acts  and  were   approved  by the TUMS Ethical Committee.     Results     Liposome characterization   The  liposomes  were  morphologically  multi - lamellar  ve sicles,  as  observed  under  optical  microscope.   The  mean  diameters  calculated  by particle size analyzer were  1.01  ±  0.45  and  1.3  ±  0.3  µm (n=3) for liposomal CpG ODN  and  empty  liposome,  respectively.   The  en - trapment of CpG ODN in liposomes was es - timated to  be more than 9 5% .        L esion  size   Footpad  swelling in mice received  L. major   mixed with  liposomal form of CpG   ODN was  significantly  ( P <0.01)  smaller  than  control  group s  which received  L. major  in PBS or  L.  major   mixed  with  empty  liposomes .   In  the  group of  m ice,  received  L. major  mixed with  liposomal form of CpG ODN , o nly induration  was  induced  and  no  ulcer  was  seen  in   the  footpad  of   any of the  mice .   The   mean average  of foot p ad swelling  in this group  showed to  increase up to 6  weeks  after inoculation   with   max imum   thickness  of   1.14   mm and  the n  the  lesion  size  started  to  decreas e d   thereafter   which  ultimately  reached to 0.23   mm  at  week  14  ( Fig .   1) .   The average  footpad  thickness  in the group  of  mice  that received  L. major   mixed with  free   CpG  ODN  was  significantly   ( P   <   0.001)   smaller than  group s   received  either  L. major   in PBS   or mixed with empty liposomes .   In th e  group  of  mice ,   which  received  L.  major   mixed  with  free   CpG  ODN ,  the  average  of  footpad  thickness  increas ed   up  to  4   weeks  after inoculation with  maximum   th ickness   of   0.85   mm  and  thereafter the lesion size  started  to  decrease  and  reached to   0.20 mm at  week  14  post - infection . In this  group,   only one out  of  10  mice  developed  an  ulcer  on  week  5,  which  was  self - healing  and completely healed  by  week 12.  Hejazi et al.: The Role of Liposomal  Cp g ODN…     50   Ulcer was  seen in group of  mice received  L.  major   in PBS  at  week  5  post - in oculation  with  an average  lesion  thicknes s   of   2.75 mm and  from week  14 ,  the  infected  foot  started to fall .   The  average thickness of lesion was 2.7 8  mm  in mice received  L. major  mixed  with  lipo - somes .   There was no significant difference  in  footpad  swelling  in  mice  received  L.   major   with empty liposome and the mice received  L.  major  in PBS .   There was no significant difference between  the  average of footpad swelling in  the group,  which received  L.  major  in CpG ODN,   and  group, which  received  L. major  in   liposomal   form of   CpG ODN   (Fig.1) .     De ath rate   In the  g roup  of  mice,   received  L. major  mixed  with  CpG ODN, only one  (10%)  mouse died  at   week  20  after  in fection  and no  more  death  was seen  up to 6 mont h s   after  the  inoculation .     In group of    mice  received  L. major  mixed  with  liposomal  form  of  CpG  ODN,  one  mouse  died  at  week  15,   two   mice   died  at   week  18,  one  mouse died at week 19 and one  mouse died at week 23 post - infection there - fore  a  total  of  5  mice  ( 5 0% )   died  up  to  6  months .   The  mice   that  received  L.  major   in  PBS ,   2  mice  died  at week   14,   3 mice  died  at week 15,   one  mouse  died  at  week 16 and 4 mice  died  at  week  17  post - infection , a total of 10  (100%)   died up to week 17 .     Concerning t he  mice  that receive d  L. major   with  empty liposome , 2 mice  died  at week 15,   2 mice  died  at week 16,   3 mice  died  at week  17 and 3 mice at week 18   post - infection  and a  total of 10  (100%)  died by week 18  (Fig.   2) .                 Fig. 1 :  Footpad swelling in BALB/c mice inoculated in th e right footpad with 2 × 10 6  L. major  promastigotes  SC together with PBS, soluble CpG ODN, liposomal CpG ODN or empty liposomes. The footpad thick - nesses of mice were measured for 14 weeks. Each point represents the average increase in footpad thickness  ±  standard error of the mean (n =10)    Iranian J Parasitol: Vol. 5, No.1, 2010, pp . 47 - 54       51         Fig. 2 :  Death rate in BALB/c mice inoculated in the right footpad with 2 × 10 6  L. major  promastigotes SC  together with PBS, soluble CpG ODN, liposomal CpG ODN or empty liposomes     Discussion     Leishmanization is cons idered  the  most  ef - fective   tool  to  protect  against  CL . It  is  also   an  effective  tool  to  evaluate  efficacy  of  Leishmania   candidate  vaccines  ( 5,8 - 1 0 ) .   However, due to  the  problems associated  with  leishmanization  such as  lack of  con - trol over the  lesion  develo pment and heal - ing process ,  it  was stopped except in Uz - bekistan  ( 5 ) .   CpG  ODN  as  an  immu - nostimulatory  adjuvant  was  used  as  monotherapy  against   cancer  ( 21 ),   and  in  conju nction  with  an   allergen  to   improve   the   immunogenicity  of   an   antigen  and  at  the  same  tim e  to  reduce   its  allergenicity   ( 22 ) .   CpG  ODN  is  also  used  to  induce  protection  against  infectious  disease  such  as  h epatitis  B  ( 23 ),  l isteriosis  ( 24 )  and  m alaria  ( 25 )  . CpG  ODN  was  used  as  an  adjuvant mixed with different  Leishmania   antigens  to  induce  protect ion  in  murine  model  of  leishmaniasis  ( 13,14 ).   The  admini stration   of  L. major  ribosom al  pro - teins (LRP)   along with CpG ODN  induce d   protec tion  against  L.  major   infection  in  BALB/c mice . Footpad swelling   of LRP +  CpG - ODN  immunized   mice  was  signifi - cantly  lo wer  than  the  control   group  re - ceived  LRP alone   ( 14 ).   In addition, immu - nization of BALB/c mice with autoclaved   L. major  (ALM) along with CpG ODN  in - duced  protection  against  challenged  with  L.  major   at  week  12  after  immunization   ( 13 ).   CpG  ODN  used  in  this  s tudy  pro - motes Th1 response, the type of response  required to induce protection in leishmani - asis ( 19 ).   Mendez  et al .   (26)  showed that   when  C57BL/6   m ice  infected  intrader - mally  with  L.  major  mixed with  50µg   CpG  ODN  with  or  without  ALM  showed  a  much milder  lesions  compared to the  con - trol  groups ,  in  addition  the   experimental  group   of m ice were pro tected against     L.  major   challenge  for  up  to  6  months .   BALB/c mice  are highly susceptible to  L.  major   infection ,   u pon  infection  the   mice   develop  skin  lesions,  whic h   expand  and  me tastasize,   and  eventually  every  mouse  suc cumbed to the disease   ( 27 ) .  In the pre - sent study,   susceptible BALB/c mice  were  in fected  with  L.   major   mi xed with 10   µg of  CpG ODN  encapsulated in liposomes or in  free  form,  the  lesion  development  and  death  rate was  compared with the control  groups.   The results  showed that  co - administration  of CpG ODN with  L.   major  in susceptible  BALB/c mice  even   with  a lower dose  i.e.  10  µ g  compared  with  50  µ g  used   previ - ously  by  others   ( 26 ) ,   induce d   a  signifi - cant ly smaller lesion size with significantly Hejazi et al.: The Role of Liposomal  Cp g ODN…     52   lower death rate.   Liposome s  as system for  carrying drugs,  pro teins,  and DNA  protect  encapsulated content from damages caused  by environmental en zymes  like endonucle - a se  ( 16 ).   In  a  study, BALB/c mice immu - nized  wi th  rgp63  plus  CpG  ODN  encap - sulated in liposomes or rgp63 mixed with  CpG  ODN  in  soluble  form,  upon  chal - lenged with  L. major ,   there  was  a  signifi - cant (p<0.05) difference between  the lesion  size  in  mice  immunized  with  rgp63 - CpG  ODN and  the  control group up  to week 11  after  challenges  but  thereafter  the  lesion  size was not significant ly different,   but  the  lesion size in  group  which   received  rgp63 - lip - CpG ODN up to 14 weeks post  chal - lenge  was significantly  ( P <0.001)  smaller  than  the  con trol group  (18) .   In t he present study , the group of mice re - ceived  L.   major  mixed with  CpG ODN en - capsulated  in  liposome ,  only  induration s  w ere   seen  in  the  experimental  group  of  mice and no ulcer was seen up to 6 months  after infection.   No significant different was  seen betwee n av erages of footpad swelling  of  the  group  which  received  L.  major   mixed with CpG ODN en capsulated in li - posomes, and the group re ceived  L. major   mixed with free form of CpG ODN.    The groups of mice  that  received   L. major   mixed  with  CpG  ODN  encapsulate d  in  lipo some s ,  or  L.  major   mixed  with  free  form  of  CpG  ODN,  a  significantly  ( P <0.05)  lower death rate was seen  com - pared  with  the  control  groups  up  to  6  month  period  after inoculation ;   one  death  out of 10   mice  in group  which  re ceived  L.  major  mixed with  CpG ODN in free form  and  5  death  out  of  10  mice  in  group re - ceived  L. major  mixed with CpG ODN en - capsulated  in  liposome   were  seen .  Al - though  the death rate was lower in group  of mice re ceived  L. major  mixed with CpG  ODN  in  free  form  than  the  group  which   received  L. major  mixed with CpG ODN  encapsulated in lipo some but  there was no  significant  difference  in  lesion  size  be - tween the  two  immunized  groups .   To  increase  immunostimulatory,  CpG  ODN  was  encapsulated  into  liposomes ,   p hos phorothioate CpG ODN  whi ch is used  i n this study is  resistan t  to  in vivo   degrada - tion by endonuclease  enzymes .  Based on  this theory, i t was anticipated that encap - sulation of CpG ODN in liposomes  will  be  result ed  in  a  lower lesion size  and  a  lower  death rate in mice. However, as  shown in  Fig.  1,  there  is  no  sig nificant  difference  between mice received CpG ODN in lipo - somal form  and mice re ceived CpG ODN  in soluble  form, which  might be due to the  lipid  used  in  liposome  formulation  (i.e.  DSPC).  DSPC has  a  very  high transition  temp erature  (Tm  55°C)  and  produces  a  very  rigid  and  stable  bilayer  structure  in  liposome formulation  ( 28 )  and as a  result,   it does not destroyed easily in phagosome  of target cells. Hence, there would not be  enough   free   CpG  ODN  available  in  phagosome to intera ct  with its specific re - ceptor, i.e.  TLR9,  localized in phagosome  ( 29 ) . In terms of  mice, which  received free  form of CpG ODN, there is one theory that  free CpG ODN may interact with TLR9 re - ceptor more effectively than those encap - su lated in very rigid a nd stable liposomes ,  also  phosphorothioate  backbone  in  this  type of CpG ODN  is not damaged  by  en - donuclease  in vivo .   The results of current  study  suggest  that  further  studies  are  needed to  identify a  suit able lipid  to for - mulate  the  liposomes, which   relea se their  content, i.e. CpG ODN ,   on an appropriate  time  to interact with TLR9.    In conclusion,  the  results showed that  co - in oculation  of  CpG  ODN  with  L.  major   induce  a  milder  leishmanization  lesion  c ompare d  to the control group  and  might  be  appropriate to  use  in combination with  it .       Acknowledgments     The authors would like to appreciate  Dr M.  Nateghi  Rostami  and   Mrs  A.  Mir amin  Mohammadi,   for  their valuable lab work ,  Center for Research and Training in Skin Iranian J Parasitol: Vol. 5, No.1, 2010, pp . 47 - 54       53   Dis eases and Leprosy and  Isfahan  Univer - sity  of  M edical  Science s   and  Mashhad  University of Medical Sciences  for finan - cial support s .  The authors declare that they  have no conflicts of interest.      References   1 .   Leishmaniasis -   disease  informa tion.  World  Health  Organization,  Geneva  Switzerland.  2004    Avail ab le  from:  http:// www.who.int/tdr/disease/leish/di s easeinfo.html   2 .   Daneshvar   H,  Graham  H.  Coombs,  Hagan  P,  Stephen  Phillips  R.  Leishmania mexicana and Leishma nia  ma jor:Attenuation  of  wild - type  para - sites and vaccination with the at tenu - ated lines. Infect Dis. 2003; 187:1662 – 8.   3 .   Khamesipour A, Rafati S, Davoudi N,  Mahboudi  F.  Leishmaniasis  vac cine  candidates for develop ment: a global  overview.  Indian  J  Med  Res.  2006;  123: 423 - 27.   4 .   Rivier D , Shah R, Bovay P, Mauel J.  Vac cine development against cutane - ous leishmaniasis.  Subcuta neous ad - mini stration  of  radioat tenuated  para - sites pro tects CBA mice against viru - lent  Leishmania  major  challenge.  Parasite Immunol. 1993; 15:75 - 84.   5 .   Khamesipour  A ,  Dowlati  Y ,  Asilian  A ,  Hashemi - Fesharki  R ,  Javadi  A ,  Noazin S ,  Modabber F . Leishmaniza - tion: Use of an old method for evalua - tion  of  candi date  vaccines  against  leishmaniasis.  Vaccine.  2005;  23:3642 - 8.   6 .   Noazin S, Modabber F, Khamesi pour  A  et  al.  First  generation  leishmani - asisvac cines:A revi ew of field effi cacy  trials. Vaccine. 2008; 26: 6759 - 67.   7 .   Noazin S,  Khamesipour  A,  Moul ton  LH  et  al.  Efficacy  of  killed  whole - parasite vaccines in the pre vention of  leishmani asis:  a  meta - analysis.  Vac - cine. 2009; 27: 4747 - 53.   8 .   Nadim A, Javadian E, Tahvil dari - Bi - druni GH, Ghorbani M. Effective ness  of leishmanization in control of cuta - ne ous  leishmaniasis.  Bull  Soc  Path  Exot. 1983; 76:397 - 383.   9 .   Nadim A, Javadian  E, Mohebali M.  The experience of leishmanization in  the  Is lamic  Republic  of  Iran.  East  Mediter r Health J. 1997; 3:284 - 289.   10 .   Greenblatt CL. The present and fu ture  of vaccination for cutaneous leishma - niasis .   Prog  Clin  Biol  Res.  1980;  47:259 - 285.   11 .   Klinman DM, Currie D, Gurse I, Ver - the lyi D. Use of CpG oligode oxynu - cleo tides  as  immune  adju vants.  I m - munol Rev. 2004; 199:201 - 16.   12 .   Krieg A M. CpG motifs in bacterial  DNA and their immune effects. Annu  Rev Immunol. 2002; 20: 709 - 760.    13 .   Rhee  EG ,  Mendez S ,  Shah JA ,  Wu  CY ,  Kirman  JR ,  Turon  TN ,  Davey  DF ,  Davis  H ,  Klinman  DM ,  Coler  RN ,  Sacks DL ,  Seder RA . Vaccina tion  with Heat - killed Leishm ania An tigen  or  Recombinant  Leishma nial  Protein  and  CpG  Oligode oxynucleo tides  in - duces  long - term  mem ory  CD4+and  CD8+   Tcell re sponses and protection  against Leishmania major in fection. J  Exp Med. 2002; 195: 1565 - 1573.   14 .   Iborra  S,  Parody  N,  Abánades  DR,   Bonay P, Prates D, Novais FO, Bar ral - Netto M, Alonso C, Soto M. Vac cina - tion with the Leishmania major ribo - somal  proteins  plus  CpG  oligode - oxynucleo tides  induces  protection  against  experi mental  cutaneous  leishmaniasis  in  mice.  Microbes  In - fect. 2008;  10:1133 - 41.   15 .   Zimmermann S ,  Egeter O ,  Hausmann  S ,  Lipford GB ,  Röcken M ,  Wagner H ,  Heeg K .  Cutting Edge: CpG Oli gode - oxynucleotides  trigger  protective  and  curative Th1 responses in lethal mur - ine  leishma niasis.  J  Immunol.  1998;  160: 3627 - 3630.   16 .   Gregoriadis  G.  Immunological  adju - vant: a  role for liposomes .  Im munol  Today. 1990;11:89 - 97 .  Hejazi et al.: The Role of Liposomal  Cp g ODN…     54   17 .   Jaafari  MR ,  Ghafarian  A ,  Farrokh - Gisour  A ,  Samiei  A ,  Kheiri  MT ,  Mahboudi  F ,  Barkhordari  F ,  Khamesipour A ,  McMaster WR . Im - mune response and protection assay of  recombinant major  surface  glyco pro - tein  of  Leishmania  (rgp63)  recon sti - tuted with liposomes in BALB/c mice.  Vaccine. 2006; 24:5708 - 5717.   18 .   Jaafari MR ,  Badiee A ,  Khamesipour  A ,  Samiei A ,  Soroush D ,  Kheiri MT ,  Barkhordari  F ,  McMaster  WR ,  Mahboudi F . The role of CpG ODN in  enhancement of immune response and  protect ion  in  BALB/c  mice  immu - nized with recombinant major surface  glyco protein  of  Leishmania  (rgp63)  en capsu lated  in  cationic  lipo some.  Vaccine. 2007; 25: 6107 - 6117.   19 .   Chu  RS ,  Targoni  OS ,  Krieg  AM ,  Lehmann PV ,  Harding CV .  Cp G oli - godeorynucleotide  act  as  adju vants  that switch on T helper1 (Thl) immu - nity.  J  Exp  Med.  1997;  186:1623 - 1631.   20 .   Kibrey  C,  Gregoriadis  G.  Dehydra - tion - Rehydration  Vesicle:  a  simple  method for high yield drug entrap ment  in lipo somes. Biotechnology. 198 4; 2:  979 - 84.   21 .   Brunner  C,  Seiderer  J,  Schlamp  A,  Bidlingmaier M,  Eigler A ,  Haimerl W ,  Lehr  HA ,  Krieg  AM ,  Hartmann  G ,  Endres  S .  Enhanced  dendritic  cell  matu ra tion by TNF - α or cytidin - phos - phate - guanosine DNA derived T cell  activation in vitro and therapeutic anti - tumo r  im mune  responses  in  vivo.  J  Immunol. 2000; 165:6278 - 6286.   22 .   Tighe H,  Takabayashi K ,  Schwartz D ,  Van Nest G ,  Tuck S ,  Eiden JJ ,  Kagey - Sobotka A ,  Creticos PS ,  Lichtenstein  LM ,  Spiegelberg HL ,  Raz E . Conjuga - tion  of  immu nostimu latory  DNA  to  the  short  ragweed  al lergen  amb  a  1  enhances its immuno genicity and re - duces its aller genicity. J Allergy Clin  Immu nol. 2000; 106:124 - 134.   23 .   Davis HL,  Suparto II ,  Weeratna RR ,  Jumintarto, Iskandriati DD,  Chamzah  SS ,  Ma'ruf  AA,  Nente  CC ,  Pawitri  DD,  Krieg AM , Heri yanto,  Smits W ,  Sajuthi  DD .  CpG  DNA  overcomes  hy porespon sive ness to hepatitis B vac - cine  in  orangutans.  Vaccine.  2000   ;  18:1920 - 1924.   24 .   Elkins  KL,  Rhinehart - Jones  TR ,  Stibitz S , Conover JS,  Klinman DM .  Bacterial DNA containing CpG mo tifs  stimulates  lymphocyte - dependent  protection  of  mice  against  lethal  in - fection  with  intra cellular  bacteria .  J  Immunol.1999; 162:2291 - 2298.   25 .   Gramzinski RA,  Doolan DL ,  Sedegah  M ,  Davis  HL ,  Krieg  AM ,  Hoffman  SL .  Interleukin - 12 - and δ interferon  – depend ent  protection  against  malaria  conferred by CpG oligodeoxynucleo - tide  in  mice.  Infect  Immun.  2001;  69:1643 - 1649.   26 .   Mendez  S ,  Tabbara  K ,  Belkaid  Y ,  Bertholet S ,  Verthelyi D ,  Klinman D ,  Seder RA ,  Sacks DL   . Coinjection   with  CpG - Containing  Immunostimu - latory  oligodeoxtnucleotides reduces  the  patho genicity  of  a  l ive  vaccine  against  cutane ous  leishmaniasis  but  maintains  its  po tency  and  durability.  Infect Immun. 2003; 71:5121 - 5129   27 .   Sacks D, Noben - Trauth N. The immu - nol ogy of susceptibility and re sistance  to Leishmania major in mice. Nat Rev  Im munol. 2002; 2:845 - 854.   28 .   Gregoriadis  G,  Florence  A.T,  Patel  H.M (Eds). Liposomes in Drug Deliv - ery, pp. 77 - 94 1993.   29 .   Ahmad - Nejad P, Hacker H, Rutz M,  Bauer  S,  Vabulas  RM,  Wagner  H.  Bac terial CpG - DNA and lipop olysac - cha rides activate Toll - like receptors at  dis tinct  cellular compartments. Eur J  Im munol. 2002; 32:1958 – 68.        